VistaGen Therapeutics
VTGN
VTGN
42 hedge funds and large institutions have $90.8M invested in VistaGen Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 46 → 42 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
42
Holding in Top 10
–
Calls
$3.76M
Puts
$1.03M
Top Buyers
| 1 | +$1.53M | |
| 2 | +$580K | |
| 3 | +$294K | |
| 4 |
Millennium Management
New York
|
+$193K |
| 5 |
State Street
Boston,
Massachusetts
|
+$181K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$821K | |
| 3 | -$602K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$524K |
| 5 |
Two Sigma Investments
New York
|
-$252K |